TherapeuticsMD, Inc.

Historical 13F Holders

Symbol
TXMD
CUSIP
88338N107
All holders as of
Q3 2022
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2022 Q3 1 16.0 $0
2022 Q2 2 13.9 k $138 k
2022 Q1 131 107 M $42.6 M
2021 Q4 147 125 M $44.5 M
2021 Q3 162 133 M $98.2 M
2021 Q2 169 173 M $206 M
2021 Q1 174 177 M $237 M
2020 Q4 174 162 M $196 M
2020 Q3 157 158 M $249 M
2020 Q2 162 156 M $194 M
2020 Q1 158 186 M $193 M
2019 Q4 189 199 M $482 M
2019 Q3 170 176 M $638 M
2019 Q2 180 193 M $499 M
2019 Q1 163 191 M $931 M
2018 Q4 160 189 M $719 M
2018 Q3 178 180 M $1.18 B
2018 Q2 162 158 M $989 M
2018 Q1 158 163 M $794 M
2017 Q4 160 163 M $982 M
2017 Q3 148 165 M $867 M
2017 Q2 127 156 M $821 M
2017 Q1 147 164 M $1.18 B
2016 Q4 161 165 M $951 M
2016 Q3 142 155 M $1.06 B
2016 Q2 132 160 M $1.36 B
2016 Q1 136 153 M $979 M
2015 Q4 135 129 M $1.34 B
2015 Q3 120 122 M $716 M
2015 Q2 121 110 M $862 M
2015 Q1 97 113 M $681 M
2014 Q4 82 95.6 M $425 M
2014 Q3 86 95.4 M $443 M
2014 Q2 91 95.1 M $421 M
2014 Q1 84 92.1 M $582 M